Clinical Trials Browser

Phase 3 × Bronchial Neoplasms × Bevacizumab × Clear all

NCT05104281 2023-03-29

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung